Table 3 |
|||
|
Odds Ratios and Confidence Intervals for hormonal contraceptive effect (HC), medroxy progesterone acetate (DMPA) effect, >4 year HC use on (a). presence and (b). severity of disease. |
|||
|
Presence of disease |
Severity of disease |
||
|
Model |
OR (CI) |
OR |
CI |
|
|
|||
|
Hormonal contraceptive use: |
|||
|
Never used |
1.0 (reference) |
1.0 (reference) |
|
|
HCa |
1.92 (1.11, 3.34) |
2.22 (1.05, 4.66) |
|
|
HC + parity + alcohol intake ab |
1.59 (0.87, 2.82) |
||
|
DMPA use: |
|||
|
Never used |
1.0 (reference) |
1.0 (reference) |
|
|
DMPAa |
2.43 (1.39, 4.57) |
2.51 (1.11, 5.64) |
|
|
DMPA + parity + alcohol intakeab |
2.48 (1.30, 4.74) |
||
|
Length of exposure:a |
|||
|
Never used |
1.0 (reference) |
1.0 (reference) |
|
|
1–4 years |
1.47 (0.80, 2.71) |
1.68 (0.73, 3.89) |
|
|
>4 years HC use |
3.56 (1.81, 7.00) |
4.43 (1.84, 10.67) |
|
|
|
|||
|
a Models were adjusted for age and number of sexual partners. ab Variables entered; age and number of sex partners, variables offered: parity and alcohol consumption. |
|||
|
McFarlane-Anderson et al. BMC Women's Health 2008 8:9 doi:10.1186/1472-6874-8-9 |
|||